Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL1151710 | 0.86 | — | — | |
| SCHEMBL503396 | 0.85 | — | — | |
| SCHEMBL8679785 | 0.85 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1 | |
| SCHEMBL6223 | 0.85 | — | — | |
| Methyl Alcohol SCHEMBL15124588 | 0.82 | — | — | |
| SCHEMBL3662439 | 0.80 | — | — | |
| Water SCHEMBL10335432 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL3840624 | 0.80 | — | — | |
| SCHEMBL3664027 | 0.80 | — | — | |
| SCHEMBL3366971 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7611880-B2 | Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-03 | — | — | US | claimed |
| US-20070207527-A1 | ENZYMATIC AMMONOLYSIS PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR DPP IV INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-09-06 | — | — | US | claimed |
| US-7223573-B2 | Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-29 | — | — | US | claimed |
| US-20050256019-A1 | Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2005-11-17 | — | — | US | claimed |
| CN-112067727-B | Gas chromatography for directly measuring seven trace amount haloacetic acids in canned tea beverage | 丁立平 | 2022-05-24 | — | — | CN | disclosed |
| CN-112067727-A | Gas chromatography for directly measuring seven trace amount haloacetic acids in canned tea beverage | 丁立平 | 2020-12-11 | — | — | CN | disclosed |
| CN-103076416-B | Method for enriching clenbuterol, ractopamine and salbutamol in urine sample of breeding livestock | UNIV NANCHANG | 2014-08-06 | — | — | CN | disclosed |
| CN-103076416-A | Method for enriching clenbuterol, ractopamine and salbutamol in urine sample of breeding livestock | UNIV NANCHANG | 2013-05-01 | — | — | CN | disclosed |
| US-20060019997-A1 | Triazole compounds and their use as metabotropic glutamate receptor antagonists | ASTRAZENECA AB | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019997-A1 | Triazole compounds and their use as metabotropic glutamate receptor antagonists | GRM3, GRIN3A, GRM1 | ALDH1A1 3228/4885TSHR 377/4885TDP1 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.